ASSAY and Drug Development Technologies

Basic Information

Brief Name: ASSAY DRUG DEV TECHN
Impact Factor: 1.6
ISSN: 1540-658X
Research Field: MEDICAL
h-index: 52
Self-citation Rate: 6.2%
Articles per Year: 30

SCI Index Status: Science Citation Index Expanded
Journal Website: https://home.liebertpub.com/publications/assay-and-drug-development-technologies/118
Journal Introduction:

ASSAY and Drug Development Technologies provides access to novel techniques and robust tools that enable critical advances in early-stage screening. This research published in the Journal leads to important therapeutics and platforms for drug discovery and development. This reputable peer-reviewed journal features original papers application-oriented technology reviews, topical issues on novel and burgeoning areas of research, and reports in methodology and technology application. ASSAY and Drug Development Technologies coverage includes: Assay design, target development, and high-throughput technologies Hit to Lead optimization and medicinal chemistry through preclinical candidate selection Lab automation, sample management, bioinformatics, data mining, virtual screening, and data analysis Approaches to assays configured for gene families, inherited, and infectious diseases Assays and strategies for adapting model organisms to drug discovery The use of stem cells as models of disease Translation of phenotypic outputs to target identification Exploration and mechanistic studies of the technical basis for assay and screening artifacts The Journal also features a dedicated Drug Repurposing, Rescue, and Repositioning (DRRR) section. These special peer-reviewed collections of papers present techniques and tools for finding new uses for approved drugs – particularly for disorders where no animal model, physiologic abnormality, biochemical pathway, or molecular target has been identified. This DRRR special section features original papers, application-oriented technology reviews, and reports in methodology and technology application to drug repurposing and redevelopment including: Designing assays and interpreting output to enable alternate drug target identification Pathway analysis and bioinformatics to identify and exploit drug promiscuity In silico technologies to identify alternate drug targets "Big Data" mining and side effect pattern analysis in clinical and healthcare repositories

CiteScore

CiteScore
3.6
SJR
0.317
SNIP
0.525
Subject Rank Percentile
Pharmacology, Toxicology and PharmaceuticsDrug Discovery
93 / 146 36%

Journal Statistics

Bimonthly
Issues/Year
Average time to initial decison: 31 days
Review Cycle
Article Processing Fee

Submission Information

Submission Website:

https://mc.manuscriptcentral.com/assay

Related Articles

Food and drugs

Other

DOI: 10.1039/AN938630604B

Erratum

Other

DOI: 10.1039/AN938630896A

Notes from the Reports of Public Analysts

Other

DOI: 10.1039/AN942670292B

Review

Other

DOI: 10.1039/AN942670278A

British Standards Institution

Other

DOI: 10.1039/AN938630734A

Front cover

Other

DOI: 10.1039/AN94368FX017

Notes from the Reports of Public Analysts

Other

DOI: 10.1039/AN940650221A

Investigation of atmospheric pollution

Other

DOI: 10.1039/AN940650462A

You might also like

Compound Q&A

What is Ethyl 3-cyclohexylpropanoate (CAS: 10094-36-7)?

Ethyl 3-cyclohexylpropanoate is a clear, colorless to light yellow liquid with a...

10094-36-7Ethyl 3-cyclohexylpr...
Compound Q&A

How should waste containing 2-(Hydroxymethyl)-5-(methoxycarbonyl)-6-methyl-4-(2-nitrophenyl)nicotinic acid (CAS: 34783-31-8) be handled?

Waste containing 2-(Hydroxymethyl)-5-(methoxycarbonyl)-6-methyl-4-(2-nitrophenyl...

34783-31-82-(Hydroxymethyl)-5-...
Compound Q&A

How should waste containing 2,4,6-Tris(pentafluoroethyl)-1,3,5-triazine (CAS: 858-46-8) be handled?

Waste containing 2,4,6-Tris(pentafluoroethyl)-1,3,5-triazine (CAS: 858-46-8) sho...

858-46-82,4,6-Tris(pentafluo...
Compound Q&A

What precautions should be taken when handling Chloroac-nle-oh (CAS: 56787-36-1)?

When handling Chloroac-nle-oh (CAS: 56787-36-1), it is essential to wear appropr...

56787-36-1Chloroac-nle-oh
Compound Q&A

What industries use Ethyl 6-phenylimidazo[2,1-b][1,3]thiazole-3-carboxylate (CAS: 752244-05-6)?

Ethyl 6-phenylimidazo[2,1-b][1,3]thiazole-3-carboxylate is primarily used in the...

752244-05-6Ethyl 6-phenylimidaz...
Compound Q&A

Are there alternatives to alpha-(2-Bromophenyl)benzylamine (CAS: 55095-15-3) in synthesis?

Alternatives to alpha-(2-Bromophenyl)benzylamine (CAS: 55095-15-3) in synthesis ...

55095-15-3alpha-(2-Bromophenyl...
Compound Q&A

How should waste containing 2-Chloro-5-methoxypyridine (CAS: 139585-48-1) be handled?

Waste containing 2-Chloro-5-methoxypyridine (CAS: 139585-48-1) should be managed...

139585-48-12-Chloro-5-methoxypy...
Compound Q&A

What industries use 1-(4-Methoxyphenyl)-2,5-dimethyl-1H-pyrrole (CAS: 5044-27-9)?

1-(4-Methoxyphenyl)-2,5-dimethyl-1H-pyrrole (CAS: 5044-27-9) is used in various ...

5044-27-91-(4-Methoxyphenyl)-...
Compound Q&A

Are there alternatives to 3-Bromo-5-(N-Boc)aminomethylisoxazole (CAS: 903131-45-3) in synthesis?

There are alternative reagents and compounds that can be used in the synthesis o...

903131-45-33-Bromo-5-(N-Boc)ami...
Compound Q&A

What is Tungsten(IV) oxide (CAS: 12036-22-5)?

Tungsten(IV) oxide, also known as tungsten dioxide, is a chemical compound with ...

12036-22-5Tungsten(IV) oxide
Disclaimer
This page provides academic journal information for reference and research purposes only. We are not affiliated with any journal publishers and do not handle publication submissions. For publication-related inquiries, please contact the respective journal publishers directly.
If you notice any inaccuracies in the information displayed, please contact us at support@chemtradehub.com. We will promptly review and address your concerns.